FDA Approves Remdesivir for the Treatment of COVID-19

It’s the first approved therapy for the disease in the United States.

remdesivir viles

Medically reviewed in October 2020

Updated on October 22, 2020

The U.S. Food and Drug Administration (FDA) approved the antiviral drug, remdesivir (Veklury), for the treatment of COVID-19 that results in hospitalization. The drug, made by Gilead Sciences, is now the first and only approved therapy for the disease in the United States.

“Since the beginning of the COVID-19 pandemic, Gilead has worked relentlessly to help find solutions to this global health crisis. It is incredible to be in the position today, less than one year since the earliest case reports of the disease now known as COVID-19, of having an FDA-approved treatment in the U.S. that is available for all appropriate patients in need,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences in a news release.

The FDA gave the drug a green light for use among adults and children age 12 and older who are at least 88lbs that have been hospitalized with COVID-19. The antiviral medication works by blocking the coronavirus’ ability to replicate.

This approval is based on three randomized controlled trials, which showed that treatment with the drug resulted in “clinically meaningful improvements” compared to placebo among people hospitalized with COVID-19. Remdesivir was shown in these clinical trials to shorten the time to recovery and reduce the progression of the disease in some patients.

“The approval of Veklury marks an important milestone in efforts to help address the pandemic by offering an effective treatment that helps patients recover faster and, in turn, helps preserve scarce healthcare resources,” said Barry Zingman, MD, Professor of Medicine at the Albert Einstein College of Medicine and Montefiore Medical Center, New York in a news release.

In May 2020, the FDA issued an emergency use authorization (EUA) for the antiviral drug as a treatment for severe COVID-19 in adults and children. In August, the agency expanded its EUA to include to include the treatment of all adults and children hospitalized with suspected or confirmed COVID-19, regardless of the severity of their infection.President Trump is among the COVID-19 patients treated with remdesivir. His medical team revealed he was treated with the drug after testing positive on October 2.

Article sources open article sources

Gilead. “U.S. Food and Drug Administration Approves Gilead’s Antiviral Veklury® (remdesivir) for Treatment of COVID-19.” Oct 22, 2020.
Physician to the President, The White House. “President Donald J. Trump and First Lady Melania Trump’s COVID-19 Tests.” October 1, 2020.
U.S. Food and Drug Administration. “COVID-19 Update: FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19.” August 2020.
Ye W, Yao M, Dong Y, et al. Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition. Front Microbiol. 2020;11:1105. Published 2020 Jun 12

More On

Pfizer and BioNTech Say Their COVID Vaccine is Safe for Younger Kids

article

Pfizer and BioNTech Say Their COVID Vaccine is Safe for Younger Kids
Pfizer and BioNTech say their vaccine is safe, well-tolerated, and effective for children between 5 and 11-years old. On September 20, the companies a...
What is MIS-C—and Should Parents Be Worried?

article

What is MIS-C—and Should Parents Be Worried?
Evidence is growing that COVID-19 vaccination for school-aged children is safe and effective. This positive news is more important than ever as cases ...
How We Got a COVID Vaccine So Quickly

article

How We Got a COVID Vaccine So Quickly
Americans have begun receiving the COVID-19 vaccine developed by Pfizer and the German drugmaker, BioNTech. The U.S. Centers for Disease Control and P...
CDC Approves Pfizer COVID Vaccine for Kids as Young as 5

article

CDC Approves Pfizer COVID Vaccine for Kids as Young as 5
Children as young as 5-years old are now eligible for a COVID vaccine. Following the recommendation of its independent panel of advisers, the Centers ...
CDC Says Fully Vaccinated People Can Gather in Small Groups Without Masks

article

CDC Says Fully Vaccinated People Can Gather in Small Groups Without Masks
Roughly 9 percent of the U.S. population, or more than 30 million Americans, are now fully vaccinated against COVID-19. And although there remains a l...